24 May 2013
Keywords: ec, clears, astrazeneca, seroquel, bd, anglo-swedish, firm
Article | 20 October 2003
Anglo-Swedish firm AstraZeneca has received European Union approval to expand the use of its atypical antipsychotic drug, Seroquel
(quetiapine), to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2003
23 May 2013
© 2013 thepharmaletter.com